Drugs / RC001
last change Dec 2025 re-read 3 minutes ago

RC001

Developed for
Dravet syndrome
Investigated by
RecoRNA(Guangzhou) Biotechnology Co., Ltd · Second Affiliated Hospital of Guangzhou Medical University

Trials 1

202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07675746 Dec 2025 → Dec 2027 expected Dravet syndrome Second Affiliated Hospital of Guangzhou Medical University Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RC001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07675746 ↗
Route Intrathecal “intrathecal RC001 in patients with Dravet syndrome” NCT07675746 ↗